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a b s t r a c t
Neuroglobin is a neuron-speciﬁc hexacoordinated globin capable of binding various ligands, including
O2, NO, and CO, the biological function of which is still uncertain. Various studies seem to indicate that
neuroglobin is a neuroprotective agent when overexpressed, acting as a potent inhibitor of oxidative and
nitrosative stress. In this study, we evaluated the pathophysiological response of the neuroglobin gene
and protein expression in the cerebral tissue of rats sustaining traumatic brain injury of differing severity,
while simultaneously measuring the oxidant/antioxidant balance. Two levels of trauma (mild and severe)
were induced in anesthetized animals using the weight-drop model of diffuse axonal injury. Rats were
then sacriﬁced at 6, 12, 24, 48, and 120 h after traumatic brain injury, and the gene and protein
expression of neuroglobin and the concentrations of malondialdehyde (as a parameter representative of
reactive oxygen species-mediated damage), nitrite þ nitrate (indicative of NO metabolism), ascorbate,
and glutathione (GSH) were determined in the brain tissue. Results indicated that mild traumatic brain
injury, although causing a reversible increase in oxidative/nitrosative stress (increase in malondialdehyde
and nitrite þ nitrate) and an imbalance in antioxidants (decrease in ascorbate and GSH), did not induce
any change in neuroglobin. Conversely, severe traumatic brain injury caused an over nine- and a ﬁvefold
increase in neuroglobin gene and protein expression, respectively, as well as a remarkable increase in
oxidative/nitrosative stress and depletion of antioxidants. The results of this study, showing a lack of
effect in mild traumatic brain injury as well as asynchronous time course changes in neuroglobin
expression, oxidative/nitrosative stress, and antioxidants in severe traumatic brain injury, do not seem to
support the role of neuroglobin as an endogenous neuroprotective antioxidant agent, at least under
pathophysiological conditions.
& 2014 The Authors. Published by Elsevier Inc.
Neuroglobin (Ngb)1 is a hemoprotein that is considered a
“hexacoordinated” globin, for the characteristics of the binding
of the heme prostetic group to the protein [1]. Although the six
coordination bonds of its iron atom are engaged in coordinating
the nitrogen of the tetrapyrrol ring (four bonds) and two histidines
of the heme pocket (two bonds), Ngb is capable of binding various
ligands, including molecular oxygen, carbon monoxide, and nitric
oxide (NO) [2], as well as forming a homodimer through the
speciﬁc oxidation of two cysteine residues and changing the
oxidation state of its iron atom [1,2]. Ngb has very recently been
discovered [3] and has the peculiarity of being located in the brain
[3], speciﬁcally in particular brain regions [4] and more speciﬁcally
in neurons and not in the other cerebral cell types [4]. Because of
the multiplicity of ligands with similar afﬁnity [2], it is not yet
clear what the biochemical role of Ngb is under physiological
conditions, although several hypotheses have been formulated
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in the past decade [5]. In particular, the interest in this protein
signiﬁcantly increased when several experimental studies evi-
denced that the gene expression and the levels of Ngb were
positively affected by cerebral ischemia [6]. Furthermore, it was
indicated that Ngb overexpression was capable of decreasing
damage induced by oxygen deprivation in cellular and animal
models of ischemia [7,8]. Such beneﬁcial effects were attributed to
the capacity of Ngb to modulate NO formation [9,10] and generally
to decrease the toxic effects of reactive oxygen (ROS) and reactive
nitrogen species (RNS) [9–12]. Therefore, in the constant endeavor
to ﬁnd new targets for effective therapies, as well as to ﬁnd
biomarkers of clinical utility, Ngb has been considered as a highly
promising macromolecule in studies of acute and chronic neuro-
degeneration [13,14].
At present, very little is known about the effect of traumatic brain
injury (TBI) on Ngb expression, with a few studies indicating Ngb
overexpression after mechanical injury [15] and neuroprotection from
TBI-associated damages in the Ngb-overexpressing animals [16].
TBI can be considered a peculiar type of acute neurodegeneration
with molecular mechanisms of cell damage strictly related to the
severity of injury [17,18]. TBI is the leading cause of death under 45
years of age in Western countries [19] and carries an enormous
socioeconomic burden: for example, in the United States, the annual
aggregated direct medical costs and indirect costs of work loss and lost
quality of life are estimated to range from $60.4 billion to $221 billion
for the civilian population alone [20]. Its incidence is on the rise and by
2020 the World Health Organization estimates that TBI will be the
largest cause of disability worldwide. Although our knowledge of the
pathobiological mechanisms of TBI-associated damage has increased
tremendously in recent years, there are no current valid therapies to
counteract the adverse effects of TBI, nor are there validated biomar-
kers to prognosticate its outcome [21]. Thanks to hundreds of studies
using different models of experimental TBI, it has been possible to
show evidence that TBI affects an incredibly vast number of neuronal
functions, including ionic balance [18,22], signal transduction [23],
mitochondrial functions [24], and gene expression [25,26].
Using the weight-drop model of closed TBI, characterized by
diffuse axonal injury, it was possible to show that the changes in
parameters representative of energy metabolism, oxidative stress, and
cerebral antioxidant defenses were deeply inﬂuenced by the severity
of TBI [27]. Furthermore, it was observed that the mitochondrial
phosphorylating capacity, concentrations of the nicotinic coenzyme
pool, and oxidative/nitrosative stress were in close correlationwith the
severity of TBI [27,28]. Particular relevance has been attributed in the
past few years to the implications that the onset of oxidative/
nitrosative stress after a TBI may have on the apoptotic process [29]
and, more in general, on the irreversible damage of the postinjured
brain tissue [30]. Interrupting the vicious circle linking mitochondrial
malfunctioning, induction of ROS and RNS, damage to macromole-
cules, and induction of apoptosis is considered a highly valuable target
for new pharmacological therapies in TBI [31].
As the pathophysiological role of Ngb and its interplay with the
oxidant/antioxidant balance after TBI have not yet been clearly
established, in this study we evaluated how diffuse mild TBI
(mTBI) and severe TBI (sTBI) affect gene expression and protein
levels of Ngb at various times after injury. We also assessed the
potential relationships of Ngb modulation with ROS, RNS, and
brain low-molecular-weight antioxidants.
Materials and methods
Experimental protocol
The experimental protocol was approved by the ethics com-
mittee of the Catholic University of Rome, according to interna-
tional standards and guidelines for animal care. Male Wistar rats
of 250–300 g were used in this study. They were randomly divided
into three groups: (1) sham-operated (control group); (2) mild
diffuse TBI (mTBI group); (3) severe diffuse TBI (sTBI group). As for
the anesthetic mixture, animals received 35 mg/kg bw ketamine
and 0.25 mg/kg bw midazolam by intraperitoneal injection. Mild
or severe TBI was induced by dropping a 450-g weight from 1 or
2 m height, respectively, according to the weight-drop impact
acceleration model [32]. Rats that suffered from skull fracture,
seizures, or nasal bleeding or that did not survive the impact were
excluded from the study. Six, 12, 24, 48, and 120 h after brain
injury, the rats (n ¼ 9 for each time point in each of the two
groups of injured animals) were again anesthetized and then
immediately sacriﬁced. Control animals were sacriﬁced 12 h after
the initial anesthesia (n ¼ 9).
Selective preparation of tissue for molecular and biochemical analyses
An in vivo craniectomy to minimize metabolite loss was
performed in all animals during anesthesia. The rat skull was
carefully removed, the brain was exposed and sharply cut along
the sagittal ﬁssure, and the two hemispheres were freeze-clamped
by aluminum tongs, precooled in liquid nitrogen, and immediately
immersed in liquid nitrogen to accelerate freezing of the tissue
and increase the recovery of metabolites [33]. To obtain total RNA,
one hemisphere was extracted in Trizol (Invitrogen Life Technol-
ogies), using the Ultra-Turrax homogenizer (Janke Kunkel, Staufen,
Germany) at 24,000 rpm/min, producing a ﬁnal 10% homogenate
(wt/vol).
To perform Ngb quantiﬁcation, one brain hemisphere was
homogenized in 15 mM KCl þ 1 mM KH2PO4, pH 7.4, at
24,000 rpm/min for 90 s in the cold, followed by centrifugation
at 18,690 g for 15 min at 4 1C.
Efﬁcient deproteinization of the tissue for metabolite analysis,
ensuring no loss of oxidizable compounds, was achieved according
to the organic solvent deproteinizing procedure described in detail
elsewhere [34].
To obtain simultaneous measurements of the parameters of
interest in six animals at each time point and for both levels of
injury, the hemispheres of three animals were processed for RNA
and protein extraction, the hemispheres of three animals were
processed for RNA and metabolite extraction, and the hemispheres
of three animals were processed for metabolite and protein
extraction. Using this protocol for tissue manipulation and properly
mixing the different processing of the right and left hemispheres,
the concomitant evaluation of parameters reﬂecting oxidative/
nitrosative stress, tissue antioxidant defenses, and Ngb gene
expression and quantiﬁcation was obtained in six hemispheres
(three right þ three left hemispheres) using nine animals for each
time point.
Gene expression of Ngb
RNA extracted from brain samples was reverse transcribed to cDNA
using a Superscript II reverse transcriptase kit (Invitrogen). From each
sample, 1 mg of total RNA, 500 ng of oligo(dT) primers (Roche
Molecular Biochemicals, UK), and 200 U of Superscript II, in a total
volume of 20 ml, were incubated at 42 1C for 60 min. The concentration
and purity of the resulting cDNA were then determined with a ND-
1000 UV–Vis spectrophotometer (NanoDrop). RT-qPCR with melting
curve analysis was performed in a Bio-Rad iQ5 real-time PCR detection
system (Bio-Rad, USA). In each reaction, 100 ng of cDNA was mixed
with 25 ml 2 SYBR Green PCR Master Mix (Applied Biosystems) and
proper primers (300 nM ﬁnal concentration) in a ﬁnal volume of 50 ml.
The thermal proﬁle began with incubation at 95 1C for 10 min,
followed by 40 ampliﬁcation cycles alternating 94 1C for 15 s and
60 1C for 60 s. To conﬁrm the speciﬁcity of reactions, a melting curve
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was produced by conducting 81 melting cycles of 30 s every 0.5 1C,
from 55 to 95 1C. Data were analyzed by the iQ5 Optical System
software (Bio-Rad).
Primers were designed with the 0.2 version of the Primer3
Input software developed by the Whitehead Institute for Biome-
dical Research (Cambridge, MA, USA) and using as template the
sequences of Rattus norvegicus Ngb (NM_033359.3) published by
the National Center for Biotechnology Information. The following
primer sequences were used: Ngb forward, 50-CCTGTCTCCA-
CAGCCTCTTC-30; Ngb reverse, 50-ACGGCACAGAGCAAGAAAGT-30.
For accurate gene expression measurements with RT-qPCR, results
were normalized to the housekeeping gene ubiquitin C of R.
norvegicus (Ubc NM_017314.1), selected using the geNorm House-
keeping Gene Selection Kit (Primer Design Ltd.) from 12 candidate
reference genes. Changes in transcript abundance of Ngb were
calculated using the 2ΔΔCT method as described by Livak and
Schmittgen [35].
Quantiﬁcation of Ngb
Ngb was quantiﬁed using the immunoenzymatic ELISA kit
(Cusabio Biotech, Wuhan, China) according to the instructions of
the manufacturer. Brieﬂy, 100 ml of standards and supernatants of
brain homogenates were incubated in microplate wells precoated
with antibody speciﬁc for Ngb. After incubation, biotinylation, and
conjugation with streptavidin–horseradish peroxidase, plates were
incubated for 30 min at 37 1C with 3,30,5,50-tetramethylbenzidine.
The reaction was stopped by addition of 50 ml of acidic solution
and absorbance of the resulting yellow product was measured
spectrophotometrically at 450 nm (Molecular Devices, Sunnyvale,
CA, USA). Using this protocol, the standard curves for Ngb were
linear in the range 15.6–1000 pg/ml.
Determination by HPLC of malondialdehyde, ascorbate, GSH, nitrite,
and nitrate
Malondialdehyde (MDA), ascorbate, GSH, nitrite, and nitrate
were measured in 20 ml of deproteinized brain extracts by high-
performance liquid chromatography (HPLC). When referring to
ascorbate and GSH, it is intended throughout the text that only the
fully reduced forms of ascorbate and GSH were considered,
separated, quantiﬁed, and calculated in samples of brain extracts.
The various compounds were separated and quantiﬁed according
to an ion-pairing method formerly set up in our laboratory [34,36]
and using a Hypersil C-18, 250 4.6-mm, 5-mm particle size column,
provided with its own guard column (Thermo Fisher Scientiﬁc,
Rodano, Milan, Italy). The HPLC apparatus consisted of a Spectra-
System P4000 pump system (Thermo Fisher Scientiﬁc) and a
highly sensitive UV6000LP diode array detector (Thermo Fisher
Scientiﬁc), equipped with 5-cm light-path ﬂow cell and set up
between 200 and 300 nm wavelengths. The method allows the
direct determination of the aforementioned compounds in depro-
teinized tissue extracts, with no sample derivatization [34,36,37].
MDA and ascorbate were detected at 266 nmwavelength, whereas
GSH, nitrite, and nitrate were revealed at 206 nm wavelength. The
suitability of these chromatographic conditions for nitrite and
nitrate quantiﬁcations, as well as the comparison with other
analytical techniques, has been fully described in a previous study
[38]. Assignment and calculation of the various compounds in
chromatographic runs of brain samples were performed by com-
paring retention times, absorption spectra, and area of the peaks
to those of chromatographic runs of mixtures containing known
concentrations of true MDA, ascorbate, GSH, nitrite, and nitrate.
Statistical analysis
The within-group comparison at each time was performed by
one-way analysis of variance. Differences across groups were
estimated by two-way analysis of variance for repeated measures.
Fisher’s protected least square was used as the post hoc test.
Differences were regarded as statistically signiﬁcant at a value of
p o 0.05.
Results
Effects of graded TBI on gene and protein expression of Ngb
Data reported in Fig. 1 illustrate the time course changes in
gene (Fig. 1A) and protein expression (Fig. 1B) of Ngb after mild or
severe TBI. A strikingly different postinjury gene modulation was
recorded in mTBI rats compared to what we observed in animals
subjected to sTBI. After an mTBI, the expression of the gene
encoding Ngb signiﬁcantly increased only at 48 h postinjury
(þ79%, p o 0.01 with respect to controls), with no differences
compared to the preimpact value at either the earlier or the later
time points after trauma. When animals experienced an sTBI,
a dramatic increase in the gene expression of Ngb (þ929%, p o
0.0001 with respect to controls) was already evident at 6 h
postinjury. Increases over the preimpact value of þ490, þ171,
and þ133% (p o 0.001 compared to controls) occurred at 12, 24,
and 48 h, respectively. At 120 h after sTBI, a decrease of 60% in the
gene expression of Ngb was recorded (p o 0.01 with respect to
controls). Comparing the gene responses after mTBI and sTBI
(Fig. 1A), it was observed that Ngb gene expression was signiﬁ-
cantly higher in sTBI rats at 6, 12, and 24 h (p o 0.001 compared
to mTBI-injured rats), whereas no difference or lower values (p o
0.01 compared to mTBI-injured rats) were observed at 48 and
120 h postimpact, respectively.
As expected, mTBI-injured rats showed no signiﬁcant changes
in the Ngb levels at any time point postinjury, even though a
tendency to increase at longer times postimpact was observed
(Fig. 1B). Conversely, sTBI caused Ngb to increase to 522, 334, 270,
and 210 pg/mg protein (p o 0.001 compared to controls) at 12, 24,
48, and 120 h after trauma, respectively, thereby indicating that
the increase in gene expression was accompanied by an increased
synthesis of Ngb (Fig. 1B). Comparing the two levels of injury,
it was possible to observe that Ngb was signiﬁcantly higher in sTBI
rats at 12, 24, 48, and 120 h after trauma (p o 0.001 compared
to mTBI rats), suggesting a differential neuronal response as a
function of the severity of injury.
Oxidants and antioxidants after graded TBI
Because one of the possible biological roles of Ngb is to protect
neurons from damage mediated by increased oxidative/nitrosative
stress [11,12], we measured parameters related to overproduction
of ROS (MDA) and RNS (nitrite and nitrate) to evaluate the effect of
excess oxidants. The simultaneous determination of ascorbate and
GSH allowed the evaluation of changes in low-molecular-weight
antioxidants after graded TBI.
In Fig. 2, the time course changes of MDA (Fig. 2A) and of nitrite
þ nitrate (Fig. 2B) are illustrated. Mild TBI produced a signiﬁcant
increase in MDA from 3.672.9 (value of controls) to 31.178.5 and
11.474.9 nmol g wet wt, respectively, at 6 and 24 h postinjury (p o
0.001 compared to controls). At the subsequent time points after
mTBI, MDA levels returned to preimpact values and no differences
were observed compared to sham-operated rats. In contrast, sTBI
caused a much more evident increase in cerebral MDA, with values
signiﬁcantly higher than those of controls at any time postinjury.
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In particular, maximal concentration of MDA was recorded at 12 h
postinjury (74.1711.2 nmol/g wet wt; p o 0.0001 with respect to
controls); at longer times after impact, MDA slowly decreased,
showing a concentration of 30.877.5 nmol g wet wt even at 120 h
after trauma (p o 0.0001 compared to controls). It is worth
emphasizing that mildly injured animals had signiﬁcantly lower
MDA levels compared to those measured in severely injured rats at
any time point after trauma occurrence (p o 0.0001).
As shown in Fig. 2B, the increase in oxidative stress was
accompanied by an increase in RNS production causing a con-
comitant sustained nitrosative stress. Therefore, although a sig-
niﬁcant rise in the sum of nitrite þ nitrate in mTBI rats with
respect to control values was recorded only at 12 (þ30%) and 24
(þ25.9%) h postinjury (p o 0.01), the concentration of these ions
deriving from metabolism of NO in sTBI rats was signiﬁcantly
higher than both the preimpact value (p o 0.0001) and any of the
values recorded in mTBI rats after trauma (p o 0.0001).
As expected, the differential effect of graded TBI on excess
oxidants caused different changes in brain antioxidants. The time
course changes of ascorbate in mTBI rats (Fig. 3A) were character-
ized by a signiﬁcant decline at 6 h (9.2%; p o 0.05 compared to
controls) and 12 h postinjury (16.2%; p o 0.01 with respect to
controls), followed by a rapid normalization up to values of the
sham-operated rats. On the other hand, sTBI induced a dramatic
and irreversible depletion of cerebral ascorbate, which was sig-
niﬁcantly decreased (p o 0.0001 compared to controls) at 6
(34%), 12 (47.7%), 24 (50.8%), 48 (54.1%), and 120 h
(51.3%) after trauma induction. These signiﬁcant differences
were observed at any time postinjury comparing ascorbate values
for mTBI and sTBI (p o 0.0001).
Similar effects were recorded for GSH, the concentrations of
which were reversibly depleted in mTBI only. In fact, rats experi-
encing this level of injury had signiﬁcantly depleted GSH values
only at 24 h after injury, when a 13.2% decrease with respect to
controls was recorded (p o 0.01). A steady decline in the cerebral
GSH content was instead measured in sTBI, starting from the
early times postinjury. In these animals, GSH levels at any time
postinjury were signiﬁcantly lower than both control values (p o
0.0001) and those determined in mTBI rats at corresponding times
(p o 0.0001).
Discussion
Since its recent discovery [3], Ngb has been hypothesized to act as
a neuroprotector in view of the fact that its overexpression signiﬁ-
cantly reduces cerebral tissue injury in experimental models of brain
ischemia [7,8]. These conclusions were drawn despite the unclear
physiological function of the protein, which is present only in
neurons [39], is not uniformly distributed throughout the brain
[40], and is found in relatively modest concentrations [4,5]. However,
its characteristics of binding reversibly not only to oxygen, but also to
Fig. 1. Time course of the (A) gene and (B) protein expression of neuroglobin in
brain homogenates of rats subjected to mild or severe traumatic brain injury.
Each point represents the mean value obtained from six different brain samples
(three left þ three right hemispheres). Standard deviations are represented by
vertical bars. Signiﬁcances have been omitted for the sake of clarity and are
described in the text.
Fig. 2. Concentrations of (A) malondialdehyde (MDA) and (B) nitrite þ nitrate
recorded in deproteinized brain homogenates of rats at various times after a mild
or a severe traumatic brain injury. Each point represents the mean value obtained
from six different brain samples (three left þ three right hemispheres). Standard
deviations are represented by vertical bars. Signiﬁcances have been omitted for the
sake of clarity and are described in the text.
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NO [2]; being located within mitochondria [41,42]; and interacting
with cytochrome c during apoptosis [43,44] allowed one to postulate
that the neuroprotection exerted by Ngb may be due to its capacity
to intervene, directly or indirectly, in the mechanisms modulating
oxidative/nitrosative stress, mitochondrial functions, and apoptosis
[9,44].
Data reported in this study clearly showed that TBI affects the
gene and protein expression of Ngb in a manner related to both
the severity of the injury and the time postinjury, thereby
suggesting that the modulation of this protein might play a
signiﬁcant role in the pathobiology of traumatic brain injury.
According to our results, however, it is unclear what the biochem-
ical meaning of the observed TBI-mediated Ngb modulation might
be. In fact, we found that in our mTBI rats a mild injury provoked a
transient, yet conspicuous, increase in MDA due to ROS-mediated
lipid peroxidation (Fig. 2A), increase in nitrite þ nitrate due to
elevated NO and RNS generation (Fig. 2B), and decrease in the low-
molecular-weight antioxidants ascorbate and GSH (Fig. 3A and B).
This was accompanied by almost no changes in Ngb gene and
protein expression (Fig. 1A and B), suggesting that this protein
does not play a signiﬁcant role in the transient changes related to
oxidant/antioxidant balance after an mTBI, i.e., Ngb has no
neuroprotective effects toward ROS- and RNS-mediated damage.
On the other hand, even the results that we obtained in sTBI rats
do not seem to support the notion that links Ngb to neuroprotection:
in fact, induction of a severe diffuse TBI caused a relevant modulation
of Ngb gene and protein expression, with an evident increase in gene
expression after 6–24 h and remarkably high protein levels 24–120 h
after impact (Fig. 1A and B), which coincided with the maximal
concentrations of MDA (deriving from sustained ROS-mediated lipid
peroxidation) and nitrite þ nitrate (originating from protracted NO
overproduction). Furthermore, notwithstanding the increase in Ngb in
the 24–120 h period after injury, the two most abundant hydrophilic
antioxidants, ascorbate and GSH, showed a steady and irreversible
depletion. If Ngb had a signiﬁcant neuroprotective effect, we would
have expected either an asynchrony between increase in Ngb and
parameters of oxidative/nitrosative stress or a recovery of antioxidants.
Numerous experimental studies demonstrated that overex-
pression of Ngb effectively counteracted tissue injury induced by
experimental ischemia [7,8]; however, recent data showed that
even Ngb-null mice have a reduced infarct size compared to
control wild type [45]. Paradoxically, the same authors recently
reported that mice overexpressing Ngb had reduced brain infarct
size caused by permanent middle artery occlusion [40]. Therefore,
apart from the Ngb-null mice study [45], it seems to be generally
accepted that Ngb overexpression is beneﬁcial in the case of
experimental ischemia [7,8,40]. Even in the case of TBI, Ngb
overexpression has been associated with neuroprotection [15,16].
Clinically, it was demonstrated that Ngb polymorphisms inﬂu-
enced the outcome of TBI patients [46] and that Ngb immunor-
eactivity increased in the cortical peri-infarct region of patients
with ischemic stroke [47]. These data contributed to reinforcing
the concept that Ngb may represent a novel target for the
pharmacological therapy of various neurological disorders [48],
even though neither the physiological nor the pathological roles of
Ngb have been fully understood. Anyhow, when demonstrated,
Ngb overexpression after brain injury is interpreted as an attempt
to decrease neuronal damage mainly associated with increased
oxidative/nitrosative stress.
The neuronal modulation of Ngb after ischemia [6] is similar to
the positive modulation of Ngb occurring after graded TBI
recorded in our experiments; however, the data referring to the
oxidant/antioxidant balance recorded in both mTBI- and sTBI-
injured rats, and connected to ROS and RNS overproduction,
do not seem to corroborate the notion that an increase in Ngb
equates to reduced brain injury. Although the severe level of TBI is
associated with irreversible brain injury [27,28,49], mTBI causes
only transient alterations in the absence of visible histological
damage [27,50]. Therefore, mTBI would have been a suitable grade
of injury to observe a time course of eventual Ngb overexpression
mirroring the recovery period from the transitory oxidant/anti-
oxidant imbalance. Conversely, our mTBI rats did not show any
change in Ngb gene or protein expression.
Our results indicate that Ngb overexpression is proportional to
the level of injury, the biological meaning of which is unclear.
In comparison with the experiments conducted under conditions
of Ngb overexpression [7,8,10,40,51,52], our results reﬂect a more
realistic pathophysiological response of neurons after a traumatic
brain injury. It is also worth emphasizing that the Ngb over-
expression we measured in sTBI animals was at the levels
observed in experiments with overexpressing animals [40],
despite the fact that we used a commercial antibody for Ngb
quantiﬁcation. In fact, previous data have indicated that the use of
commercial Ngb antibodies might represent a signiﬁcant source of
variability when trying to obtain absolute Ngb concentration
[40,45,53].
Notwithstanding, in the present model of brain injury, these
levels of Ngb overexpression neither produced a decrease in NO
metabolites (nitrite þ nitrate), nor decreased ROS-mediated lipid
peroxidation, nor improved the level of brain antioxidants. This
discrepancy with previous observations might be due either to a
Fig. 3. Time course changes in the low-molecular-weight antioxidants (A) ascor-
bate and (B) GSH occurring in rats after a mild or a severe traumatic brain injury.
Each point represents the mean value obtained from six different brain samples
(three left þ three right hemispheres). Standard deviations are represented by
vertical bars. Signiﬁcances have been omitted for the sake of clarity and are
described in the text.
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transitory and not constitutive increase in protein levels occurring
in our animals or to additional roles of Ngb other than that of ROS
and RNS scavenger/modulator. The latter would be supported by
the notion that Ngb can transfer an electron to cytochrome c (Cyt c)
at a high bimolecular rate, comparable to other mechanisms of
interprotein electron transfer in mitochondria [54], where the
protein is in part localized [41,42,54].
In consideration of the very low oxygen tension found within
neurons, the relatively low Ngb concentration, and the Ngb oxygen
binding afﬁnity [2], the protein should mainly be found in vivo in
its hexacoordinated form and might actively participate in various
redox reactions, including that with Cyt c. In this case, Ngb would
efﬁciently operate as an antiapoptotic molecule [44,55] mainly
through the reduction of Cyt c, rather than through a direct
ROS- and RNS-scavenging effect. This would also explain the
minimal Ngb changes we found after an mTBI, a type of injury
characterized by no evident neuronal loss due to apoptosis/
necrosis [50], and the remarkable increase after an sTBI, an injury
associated with relevant loss of neurons caused by both apoptosis
and necrosis [56].
In conclusion, our results evidenced that, depending on the level of
injury and on the time interval after injury, Ngb gene and protein
expressions are affected by TBI with no apparent link with oxidative/
nitrosative stress, suggesting that the role of this protein under
physiological and pathological conditions might possibly be related
to other mechanisms of neuroprotection, including antiapoptotic
effects.
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